Population
Patients with acute granulocytic leukemia and solid tumors
Design
Review
Authors
Loading...
Informs early pharmacology of cytarabine and 5-azacytidine in leukemia; leaves open optimization in modern AML regimens.
This review discusses the clinical pharmacology of antineoplastic agents, specifically cytarabine and 5-azacytidine for acute granulocytic leukemia.
Chabner et al. (1975) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: